Wesana Health Holdings Past Earnings Performance
Past criteria checks 0/6
Wesana Health Holdings has been growing earnings at an average annual rate of 25.3%, while the Pharmaceuticals industry saw earnings growing at 26.2% annually. Revenues have been declining at an average rate of 136.4% per year.
Key information
25.3%
Earnings growth rate
72.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | -136.4% |
| Return on equity | -760.4% |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Wesana Health Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 0 | -3 | 2 | 0 |
| 30 Jun 23 | 0 | 0 | 0 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -3 | 3 | 0 |
| 30 Sep 22 | 0 | -2 | 4 | 0 |
| 30 Jun 22 | 0 | -2 | 4 | 0 |
| 31 Mar 22 | 0 | -6 | 5 | 0 |
| 31 Dec 21 | 0 | -6 | 5 | 0 |
| 30 Sep 21 | 0 | -6 | 3 | 0 |
| 30 Jun 21 | 0 | -8 | 4 | 0 |
| 31 Mar 21 | 0 | -3 | 1 | 0 |
| 31 Dec 20 | 0 | 0 | 0 | 0 |
Quality Earnings: WESA.X is currently unprofitable.
Growing Profit Margin: WESA.X is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if WESA.X's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare WESA.X's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: WESA.X is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (18.4%).
Return on Equity
High ROE: WESA.X has a negative Return on Equity (-760.41%), as it is currently unprofitable.